Here's How Much $100 Invested In Regeneron Pharmaceuticals 10 Years Ago Would Be Worth Today
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals (NASDAQ:REGN) has outperformed the market over the past 10 years with an average annual return of 12.35%, resulting in a $100 investment growing to $315.93. The company currently has a market capitalization of $109.21 billion.
June 03, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Regeneron Pharmaceuticals has shown strong performance over the past decade, with an average annual return of 12.35%. A $100 investment 10 years ago would now be worth $315.93.
The article highlights Regeneron's strong historical performance, which is likely to positively influence investor sentiment and potentially drive short-term stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100